PENELOPE: A randomized phase II trial of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab with or without nesuparib, in patients with newly diagnosed advanced or recurrent MMR-proficient endometrial cancer.

Authors: Se Ik Kim, Hyun-Woong Cho, Chel Hun Choi, Jeong-Yeol Park, Jung Bok Lee, Jae-Weon Kim, Byoung-Gie Kim, John Kim, Jung-Yun Lee

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps5635

Source: Full article

---

Abstract

TPS5635